Julie Beyrer

7PUBLICATIONS
19CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Bioinformatic methods developmentOther biomedical and clinical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 08, 2023
Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors.

Xi Rao, Yongmei Chen, Julie Beyrer

|Jan 20, 2023
Development and Validation of Coding Algorithms to Identify Patients with Incident Non-Small Cell Lung Cancer in United States Healthcare Claims Data.

Julie Beyrer, David R Nelson, Kristin M Sheffield

|Sep 13, 2022
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib.

Emily Nash Smyth, Julie Beyrer, Kimberly R Saverno

|Mar 17, 2022
A review of stakeholder recommendations for defining fit-for-purpose real-world evidence algorithms.

Julie Beyrer, Hamed Abedtash, Kenneth Hornbuckle

|Apr 19, 2021
Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations.

Katherine B Winfree, Cliff Molife, Patrick M Peterson

|Feb 13, 2021
Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data.

Julie Beyrer, Janna Manjelievskaia, Machaon Bonafede

Pageof 2

Frequent Collaborators

2 joint publications

Emily Nash Smyth

2 joint publications

Garreth W Lawrence

1 joint publications

Kristin M Sheffield

1 joint publications

Katherine B Winfree